Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Association of CD31 and p53 With Survival of Ovarian Cancer Patients

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Minimal Access vs. Open Spine Surgery in Patients With Metastatic Spinal Cord Compression - A One-Center Randomized Controlled Trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Neoadjuvant Chemotherapy Reduces the Treatment-free Interval After First-line Treatment in Patients With Advanced Ovarian Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Long-term Survival After Surgical Treatment of Spinal Metastasis - The Predictive Role of Sex

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Improving Photoprotection and Implications for 25(OH)D Formation

    Research output: Contribution to journalReviewpeer-review

  5. Lifetime UVR Dose and Skin Cancer Risk, Determined by Their Common Relation to Solar Lentigines

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Human papillomavirus genotype-specific risks for cervical intraepithelial lesions

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Expanding our understanding of ovarian cancer risk: the role of incomplete pregnancies

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Mucosal microRNAs relate to age and severity of disease in ulcerative colitis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Borderline ovarian tumors in Denmark 1997-2018: Time trends in incidence by histology, age and educational level

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND/AIM: New markers for ovarian cancer are needed. This study aimed to examine the expression of tumour cell p53 and endothelial cell CD31 proteins and correlate them to clinicopathological factors.

PATIENTS AND METHODS: Expression of proteins was immunohistochemically assessed using tissue sections from 585-599 ovarian cancer patients from the Danish MALOVA study.

RESULTS: High CD31 expression was found in poorly differentiated tumours (p=0.0006), and high p53 expression was found in poorly differentiated cancers (p<0.0001), high clinical stage (p<0.0001), non-radical surgery (p<0.0001) and high serum CA-125 values (p<0.0001). CD31 expression showed no prognostic survival value, but high hazard ratios were found for patients with high p53 expression (HR=2.313, p<0.0001). An interaction was found between p53 and stage of cancer, suggesting a prognostic impact of p53 in low-stage, but not in advanced-stage cancer.

CONCLUSION: More than 5% of p53 tissue expression may predict shorter survival of ovarian cancer patients and may be useful for predicting the risk of disease progression in low-stage patients following primary surgery. CD31 has no strong prognostic value.

Original languageEnglish
JournalAnticancer Research
Volume39
Issue number2
Pages (from-to)567-576
Number of pages10
ISSN0250-7005
DOIs
Publication statusPublished - Feb 2019

    Research areas

  • Biomarkers, Tumor/metabolism, Carcinoma, Ovarian Epithelial/metabolism, Cell Differentiation, Denmark, Disease Progression, Female, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, Humans, Immunohistochemistry, Kaplan-Meier Estimate, Neoplasm Staging, Ovarian Neoplasms/metabolism, Platelet Endothelial Cell Adhesion Molecule-1/metabolism, Prognosis, Risk Factors, Tumor Suppressor Protein p53/metabolism

ID: 58605882